On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, ...

As part of the three-year agreement, Gilead has agreed to take a series of actions that align with the government’s new drug ...

Novartis has announced an agreement with the US government to lower the prices of its medicines in the US and support ...

Merck (known as MSD outside the US) has announced an agreement with the US government to provide key products to patients at ...

Novo Nordisk’s Wegovy (semaglutide) pill has been approved by the US FDA as an oral weight loss medication. In addition to ...

Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story ...

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more to find out.

Japanese prosecutors have laid formal charges against Novartis in the clinical data manipulation scandal that has already claimed the jobs of several senior executives. Novartis’ local subsidiary and ...

The NHS has treated the first patient with Zolgensma, Novartis’ spinal muscular atrophy (SMA) gene therapy. Five-month-old Arthur Morgan, who was diagnosed with SMA in May, has received the once-off ...

GSK has announced it is investing over £270m to build a new vaccine manufacturing facility at its Wavre campus in Belgium. The investment follows the launch of the company’s new respiratory syncytial ...

ESMO celebrates 50 years of focusing on oncology research; Improving cardiovascular disease therapy; Global pharma pricing impact on supply chains ...

The US FDA has announced the launch of the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot, designed to promote safe access to digital health devices. The pilot ...